GO:0002432 granuloma formation: Chronic Inflammatory Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002432 granuloma formation describes the creation of nodular inflammatory lesions composed of compactly grouped T lymphocytes and modified phagocytes such as epithelioid cells and giant cells.
• Granulomas are initiated by persistent infectious or noninfectious agents and represent a chronic inflammatory response that can lead to tissue necrosis.
• Macrophage metabolic reprogramming, including activation of the pentose phosphate pathway and aberrant lipid metabolism, is crucial for granuloma formation in sarcoidosis.
• Single-cell and spatial transcriptomics have revealed aberrant lymphoid developmental programs and immune microenvironment features that drive granuloma formation.
• Defective granuloma formation has been observed in elderly infected patients, highlighting age-related immune dysfunction.
• Targeting inflammatory signals and lipid metabolism, such as through βc receptor antagonism, can mitigate sarcoidosis granuloma formation.
Description
Granuloma formation (GO:0002432) is a biological process defined as the formation of nodular inflammatory lesions, usually small or granular, firm, persistent, well-structured, and containing compactly grouped T lymphocytes and modified phagocytes such as epithelioid cells, giant cells, and other macrophages. This process represents a chronic inflammatory response initiated by various infectious and noninfectious agents, and the center of a granuloma consists of fused macrophages that can become necrotic. Granulomas are a hallmark of many diseases, including tuberculosis, sarcoidosis, and Crohn's disease, and understanding their formation is critical for developing targeted therapies. Recent advances in single-cell and spatial transcriptomics have begun to unravel the complex cellular and molecular programs driving granuloma formation, revealing aberrant lymphoid developmental programs and metabolic reprogramming in macrophages. These studies highlight the importance of granuloma formation as a research area for immunologists, infectious disease specialists, and drug developers.
granuloma formation At A Glance
| GO ID | GO:0002432 |
|---|---|
| GO term | granuloma formation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Formation of nodular inflammatory lesions containing T lymphocytes and modified phagocytes |
| Definition | The formation of nodular inflammatory lesions, usually small or granular, firm, persistent, well-structured, and containing compactly grouped T lymphocytes and modified phagocytes such as epithelioid cells, giant cells, and other macrophages. |
| Associated diseases | Sarcoidosis, tuberculosis, Crohn's disease, and other chronic inflammatory conditions |
| Key cell types | Macrophages, T lymphocytes, epithelioid cells, giant cells |
| Research methods | Single-cell transcriptomics, spatial transcriptomics, metabolic assays, CRISPR screens |
What Is GO:0002432?
Granuloma formation is the process by which the body creates organized nodules of immune cells, primarily macrophages and T lymphocytes, in response to persistent irritants that cannot be easily eliminated. These structures are firm, granular, and well-structured, with a center of fused macrophages that may become necrotic, and they represent a chronic inflammatory response.
Why Is granuloma formation Important in Cell Biology?
Granuloma formation is a central process in chronic inflammatory diseases such as tuberculosis and sarcoidosis, where it can either contain infection or cause tissue damage. Understanding the molecular and cellular mechanisms of granuloma formation is essential for developing new therapies that modulate this response, as highlighted by recent studies on metabolic reprogramming and immune signaling.
• Granulomas are a key host defense mechanism against persistent pathogens like Mycobacterium tuberculosis.
• Dysregulated granuloma formation contributes to pathology in sarcoidosis and Crohn's disease.
• Macrophage metabolic pathways, including the pentose phosphate pathway and lipid metabolism, are critical for granuloma formation.
• Age-related defects in granuloma formation increase susceptibility to infections in elderly patients.
• Spatial transcriptomics has revealed distinct immune microenvironments within granulomas, offering new therapeutic targets.
• Targeting βc receptor signaling can mitigate granuloma formation in sarcoidosis models.
• Granuloma formation involves complex crosstalk between innate and adaptive immunity.
• Single-cell technologies have identified aberrant lymphoid developmental programs in granulomas.
• The process is a model for studying chronic inflammation and tissue remodeling.
• CRISPR-based models enable functional dissection of genes driving granuloma formation.
What Happens During granuloma formation?
Initiation by Persistent Agents
In simple terms: The body encounters a stubborn invader or irritant that it cannot quickly destroy.
Granuloma formation is initiated by various infectious and noninfectious agents that persist in tissues, leading to a chronic inflammatory response. These agents can include Mycobacterium tuberculosis, fungi, or foreign bodies, which trigger an immune reaction that attempts to wall off the irritant.
Macrophage Activation and Aggregation
In simple terms: Immune cells called macrophages gather at the site and become activated.
Macrophages are recruited to the site of persistent irritation and undergo activation, often driven by metabolic reprogramming such as activation of the pentose phosphate pathway and aberrant lipid metabolism. These activated macrophages aggregate and begin to form the core of the granuloma.
T Lymphocyte Recruitment and Organization
In simple terms: T cells join the cluster, helping to organize the structure.
Compactly grouped T lymphocytes are recruited to the developing granuloma, where they interact with macrophages and contribute to the chronic inflammatory milieu. Single-cell and spatial transcriptomics have revealed aberrant lymphoid developmental programs that drive this organization.
Differentiation into Epithelioid and Giant Cells
In simple terms: Some macrophages change into specialized cells that form the granuloma's body.
Macrophages within the granuloma can differentiate into epithelioid cells and fuse to form multinucleated giant cells, which are characteristic of well-structured granulomas. These modified phagocytes contribute to the firm, persistent nature of the lesion.
Central Necrosis and Resolution
In simple terms: The center of the granuloma may die off, and the structure can persist or resolve.
The center of a granuloma consists of fused macrophages that can become necrotic, leading to caseation or fibrosis. Depending on the context, granulomas may persist for long periods, resolve, or cause tissue damage, as seen in tuberculosis and sarcoidosis.
Key Genes Involved in GO:0002432 granuloma formation
The following genes and proteins are critically involved in granuloma formation, as supported by recent literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNF | Proinflammatory cytokine central to granuloma maintenance | Targeted in autoimmune diseases; studied in tuberculosis granulomas |
| IFNG | Activates macrophages and promotes granuloma formation | Key mediator of Th1 responses in mycobacterial infections |
| IL12B | Drives Th1 differentiation and IFN-γ production | Mutations linked to susceptibility to mycobacterial diseases |
| CCR2 | Mediates monocyte recruitment to granulomas | Target for modulating monocyte infiltration |
| CXCL10 | Recruits CXCR3+ T cells to granulomas | Biomarker in sarcoidosis and tuberculosis |
| G6PD | Rate-limiting enzyme in pentose phosphate pathway | Activation crucial for sarcoidosis granuloma formation |
| SLC7A11 | Cystine/glutamate antiporter involved in lipid metabolism | Aberrant lipid metabolism in sarcoidosis macrophages |
| CSF2 | GM-CSF, promotes macrophage activation and granuloma formation | Therapeutic target in sarcoidosis |
| CSF2RB | βc receptor subunit for GM-CSF signaling | Antagonism mitigates granuloma formation |
| MTOR | Regulates metabolic reprogramming in macrophages | Central to macrophage polarization in granulomas |
| HIF1A | Hypoxia-inducible factor, responds to granuloma hypoxia | Drives metabolic adaptation in granulomas |
| PPARG | Regulates lipid metabolism and macrophage polarization | Linked to aberrant lipid metabolism in sarcoidosis |
| IL10 | Anti-inflammatory cytokine, limits granuloma size | Modulates chronic inflammation |
| TGFB1 | Promotes fibrosis and tissue remodeling in granulomas | Drives fibrotic complications |
| NOS2 | Produces nitric oxide for pathogen killing | Marker of M1 macrophage activation in granulomas |
| ARG1 | Arginase, marker of M2 macrophage activation | Associated with tissue repair and fibrosis |
| CD68 | Macrophage marker | Used for immunohistochemical identification of granulomas |
| CD3 | T lymphocyte marker | Identifies T cells within granulomas |
How Is granuloma formation Regulated?
Granuloma formation is regulated by a complex network of cytokines, chemokines, and metabolic pathways. The pentose phosphate pathway and lipid metabolism are crucial for macrophage activation and granuloma formation in sarcoidosis. The mTOR pathway integrates metabolic and inflammatory signals to regulate macrophage polarization during granuloma formation. βc receptor signaling, activated by GM-CSF, promotes inflammatory signals and aberrant lipid metabolism, and its antagonism mitigates granuloma formation. Additionally, age-related factors can impair granuloma formation, as seen in elderly infected patients.
granuloma formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| G6PD | Sarcoidosis | Knockout macrophages to assess pentose phosphate pathway role |
| CSF2RB | Sarcoidosis | Point mutation to block βc receptor signaling |
| SLC7A11 | Sarcoidosis | Overexpression to study lipid metabolism |
| IFNG | Tuberculosis | Knockout mice to evaluate granuloma formation |
| TNF | Crohn's disease | Knock-in reporter for live imaging |
Sarcoidosis
Sarcoidosis is a multisystem granulomatous disease characterized by noncaseating granulomas, most commonly in the lungs and lymph nodes. Recent studies have shown that activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis. Aberrant lipid metabolism in macrophages is also associated with granuloma formation, and targeting these metabolic pathways may offer therapeutic benefits.
Tuberculosis
Mycobacterium tuberculosis infection leads to the formation of granulomas that attempt to contain the bacteria. Spatial transcriptomic sequencing of tuberculosis granulomas in lung and omentum has revealed distinct immune microenvironment features, providing insights into host-pathogen interactions. Defective granuloma formation in elderly patients can lead to increased susceptibility to tuberculosis.
Crohn's Disease
Crohn's disease is an inflammatory bowel disease that can feature granulomas in the intestinal wall. The chronic inflammatory response driven by granuloma formation contributes to tissue damage and fibrosis. Understanding the genetic and environmental factors that trigger granuloma formation in Crohn's disease is an active area of research.
From granuloma formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X drive macrophage aggregation? | Knockout cell model (e.g., CRISPR KO in THP-1) |
| Does a specific mutation in gene Y alter granuloma formation? | Point mutation knock-in in primary macrophages |
| How does gene Z affect T cell recruitment? | Tagged knock-in for spatial tracking |
| Can overexpression of gene A enhance granuloma formation? | Overexpression cell model in macrophage cell lines |
| What is the role of gene B in metabolic reprogramming? | CRISPR library screening in macrophage differentiation |
| Does gene C regulate lipid metabolism in granulomas? | Knockout mouse model with high-fat diet |
How to Study the granuloma formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Gene expression at single-cell level | Identify cell types and states in granulomas |
| Spatial transcriptomics | Gene expression with spatial context | Map immune microenvironment in tuberculosis granulomas |
| Metabolic flux analysis | Pentose phosphate pathway activity | Assess macrophage metabolic reprogramming |
| Lipidomics | Lipid species profiling | Study aberrant lipid metabolism in sarcoidosis |
| Immunohistochemistry | Protein localization in tissue | Visualize granuloma structure |
| CRISPR knockout screening | Gene function loss-of-function | Discover regulators of granuloma formation |
| Flow cytometry | Cell surface and intracellular markers | Quantify macrophage polarization |
| ELISA | Cytokine secretion | Measure TNF, IFN-γ in granuloma models |
Single-Cell and Spatial Transcriptomics
Single-cell RNA sequencing and spatial transcriptomics have been used to reveal aberrant lymphoid developmental programs and immune microenvironment features driving granuloma formation. These methods allow researchers to map gene expression within granuloma structures and identify novel therapeutic targets.
Metabolic Assays
Metabolic assays, such as measuring pentose phosphate pathway activity and lipid profiling, are essential for understanding macrophage reprogramming during granuloma formation. These assays can be combined with CRISPR knockout models to dissect metabolic dependencies.
Immunohistochemistry and Imaging
Immunohistochemistry using markers like CD68 and CD3 allows visualization of macrophages and T cells within granulomas. Advanced imaging techniques, such as multiplex immunofluorescence, provide spatial context for cellular interactions.
CRISPR Screening
CRISPR library screening enables unbiased identification of genes that regulate granuloma formation. This approach can be applied to macrophage cell lines or primary cells to discover novel regulators of chronic inflammation.
How CRISPR Can Be Used to Study GO:0002432 granuloma formation
Knockout
CRISPR knockout models are used to delete genes such as G6PD or CSF2RB to determine their causal role in granuloma formation. These models help validate metabolic and signaling pathways identified in transcriptomic studies.
Point Mutation
Point mutation knock-in models allow precise modification of genes to mimic human disease variants, such as those in CSF2RB, to study their impact on granuloma formation. This approach is valuable for understanding how specific mutations alter protein function.
Knock-in
Tagged knock-in models, such as fluorescent reporters for TNF or CD68, enable live imaging and tracking of granuloma-associated cells. These models are essential for dynamic studies of granuloma development.
Overexpression
Overexpression models are used to study the effects of genes like SLC7A11 on lipid metabolism and granuloma formation. By driving high expression, researchers can assess gain-of-function phenotypes in macrophage cell lines.
How EDITGENE Supports granuloma formation Research
Researchers studying granuloma formation-related genes often need to determine whether a candidate gene is causally involved in the process or merely a bystander. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise functional interrogation of genes in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for granuloma formation research.
Frequently Asked Questions About granuloma formation
What is granuloma formation?
Granuloma formation is the biological process of creating nodular inflammatory lesions composed of T lymphocytes and modified phagocytes, representing a chronic inflammatory response.
What genes are involved in granuloma formation?
Key genes include TNF, IFNG, IL12B, CCR2, CXCL10, G6PD, SLC7A11, CSF2, CSF2RB, MTOR, HIF1A, PPARG, IL10, TGFB1, NOS2, ARG1, CD68, and CD3.
What diseases are associated with granuloma formation?
Granuloma formation is associated with sarcoidosis, tuberculosis, Crohn's disease, and other chronic inflammatory conditions.
How is granuloma formation studied?
It is studied using single-cell and spatial transcriptomics, metabolic assays, immunohistochemistry, and CRISPR screening.
What is the role of macrophages in granuloma formation?
Macrophages aggregate and differentiate into epithelioid and giant cells, forming the core of the granuloma, and their metabolic reprogramming is crucial for the process.
What is the pentose phosphate pathway's role in granuloma formation?
Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis.
How does lipid metabolism affect granuloma formation?
Aberrant lipid metabolism in macrophages is associated with granuloma formation in sarcoidosis, and targeting it can mitigate the process.
Can granuloma formation be targeted therapeutically?
Yes, targeting inflammatory signals and metabolic pathways, such as βc receptor antagonism, can mitigate granuloma formation in sarcoidosis.
Why is granuloma formation defective in elderly patients?
Age-related immune dysfunction can lead to defective granuloma formation, increasing susceptibility to infections.
What research methods are used to study granuloma formation?
Methods include single-cell RNA-seq, spatial transcriptomics, metabolic flux analysis, lipidomics, immunohistochemistry, and CRISPR screening.
Conclusion
Granuloma formation (GO:0002432) is a complex chronic inflammatory process central to diseases such as sarcoidosis and tuberculosis. Recent advances in single-cell and spatial technologies have illuminated the metabolic and immune programs driving this process, revealing new therapeutic targets. Continued research using CRISPR models and bioinformatics will further unravel the mechanisms of granuloma formation and aid in developing targeted interventions.
References
- 1. Krausgruber T et al.. 2023. Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation.. Immunity 56(2):289-306.e7 PMID: 36750099
- 2. Nakamizo S et al.. 2023. Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis.. J Clin Invest 133(23) PMID: 38038136
- 3. Pagán AJ et al.. 2018. The Formation and Function of Granulomas.. Annu Rev Immunol 36:639-665 PMID: 29400999
- 4. Nakamizo S et al.. 2024. Metabolic reprogramming and macrophage polarization in granuloma formation.. Int Immunol 36(7):329-338 PMID: 38441292
- 5. Lim CX et al.. 2024. Aberrant Lipid Metabolism in Macrophages Is Associated with Granuloma Formation in Sarcoidosis.. Am J Respir Crit Care Med 209(9):1152-1164 PMID: 38353578
- 6. Wang H et al.. 2025. βc receptor antagonism mitigates sarcoidosis granuloma formation by targeting inflammatory signals and aberrant lipid metabolism.. Front Immunol 16:1733060 PMID: 41476976
- 7. Daumas A et al.. 2020. Defective Granuloma Formation in Elderly Infected Patients.. Front Cell Infect Microbiol 10:189 PMID: 32411623
- 8. Qiu X et al.. 2024. Spatial transcriptomic sequencing reveals immune microenvironment features of Mycobacterium tuberculosis granulomas in lung and omentum.. Theranostics 14(16):6185-6201 PMID: 39431015
